Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
MVIR:STO
Medivir AB
SEK 1,90
-1,24%
(-0,024) 1D
30 Apr., 12:59:49 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for MVIR...
Open
SEK 1,90
High
SEK 1,95
Low
SEK 1,87
Mkt. cap
1,03 mjd
Avg. vol.
6,30 m
Volume
1,20 m
52-wk high
SEK 2,88
52-wk low
SEK 0,34
EPS
-SEK 0,66
Shares outstanding
538,67 m
No. of employees
10
News stories
From sources across the web
Profile
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies. Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides. Medivir is listed on the Nasdaq Stockholm Mid Cap List. In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
About Medivir AB
CEOChristine Lind
Employees10
Founded1988
Headquarters-
Sector-
Websitemedivir.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
600,00 k
1,50 m
1,00 m
5,51 m
Cost of goods sold
6,10 m
17,00 m
8,10 m
10,21 m
Cost of revenue
6,10 m
17,00 m
8,10 m
10,21 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,00 m
7,10 m
5,80 m
7,16 m
Operating expense
8,10 m
7,60 m
6,50 m
37,66 m
Total operating expenses
14,20 m
24,60 m
14,60 m
47,88 m
Operating income
-13,60 m
-23,10 m
-13,60 m
-42,37 m
Other non operating income
200,00 k
-
-
-500,00 k
EBT including unusual items
-13,30 m
-23,30 m
-14,60 m
-43,20 m
EBT excluding unusual items
-13,30 m
-23,30 m
-14,60 m
-43,77 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
400,00 k
-200,00 k
-
-7,00 k
Net income
-13,30 m
-23,30 m
-14,60 m
-43,20 m
Net profit margin
-2 216,67%
-1 553,33%
-1 460,00%
-784,60%
Earnings per share
-0,12
-0,20
-0,13
-
Interest and investment income
100,00 k
-
-
41,00 k
Interest expense
-
-200,00 k
-1,00 m
-1,31 m
Net interest expenses
100,00 k
-200,00 k
-1,00 m
-1,27 m
Depreciation and amortization charges
700,00 k
700,00 k
700,00 k
30,51 m
EBITDA
-12,90 m
-22,40 m
-12,90 m
-11,87 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer